Classificação Internacional das Cefaléias - HGF – Neurologia

7.9 Cefaléia atribuída a outro transtorno não-vascular
intracraniano
Critérios diagnósticos
A. Cefaléia com pelo menos uma das seguintes características e
preenchendo os critérios C e D:
1. ocorrência diária
2. dor difusa
3. agravada pela manobra de Valsalva
B. Evidência de um transtorno intracraniano diferente dos descritos
anteriormente
C. A cefaléia desenvolve-se em relação temporal estreita com o
transtorno intracraniano
D. A cefaléia resolve-se dentro de três meses após a cura ou a
remissão espontânea do transtorno intracraniano
Referências bibliográficas
7.1 Cefaléia atribuída a hipertensão liquórica
Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with
pseudotumor cerebri. Neurology 1983;33:1386–88.
Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for
pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol 1988;106:1391–7.
Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension.
Arch Neurol 1989;46:1049–51.
Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988;45:866–72.
Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa
and Louisiana. Arch Neurol 1988;45:875–7.
Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor
cerebri. Neurology 1996;46:1524–30.
Fishman RA. Cerebrospinal fluid in diseases of the nervous system, WB Saunders Company,
Philadelphia 1992.
Gamache FW, Patterson RH, Alksne JF. Headache associated with changes in intracranial
pressure. In Wolff’s headache and other head pain, (Dalessio DJ, ed.) Oxford University Press,
New York. 1987;352–5.
Gardner K, Cox T, Digre K. Idiopathic intracranial hypertension associated with tetracycline use
in fraternal twins: case report and review. Neurology 1995;45:6–10.
Giuseffi V, Wall M, Siegal PZ, Rojas PB. Symptoms and disease associations in idiopathic
intracranial hypertension (pseudotumor cerebri): A case control study. Neurology
1991;41:239–44.
Griffin JP. A review of the literature on benign intracranial hypertension. Adverse Drug React
Toxicol Rev 1992;11:41–58.
Johnson LN, Krohel GB, Madsen RW, March GA. The role of weight loss and acetazolamide in
the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmol
1998;105:2313–7.
Johnston I, Paterson A. Benign intracranial hypertension II. CSF pressure and circulation. Brain
1974;97:301–12.
Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as
a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology
1996;46:198–202.